Immunohistochemical analysis demonstrated that ezrin expression was elevated in PDAC samples compared to normal pancreatic tissues, which provided additional evidence supporting a functional role of ezrin in pancreatic cancer development. This evidence concerns the gene EZR and pancreatic neoplasm.